AGL - NYSE

Agilon Health, Inc.

AGL·NYSE

$97.68

+18%

HealthcareMedical - Care Facilities

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.63B

EPS-24.5000

P/E Ratio-3.99

Earnings Date08/03/2026

1.27B

Assets

-27%

3Y-25.0%

5Y+185.0%

10Y+216.0%

1.14B

Total Liabilities

-9%

3Y+74.0%

5Y+57.0%

10Y+80.0%

126.73M

Total Equity

-73%

3Y-88.0%

5Y-145.0%

10Y-155.0%

Agilon Health, Inc. Funding & Solvency Profile

AGL · NYSE

Current Assets

Cash & Cash Equivalents173.71M

Net Receivables673.79M

Inventory0.00

Other Current Assets137.76M

Total Current Assets1 B

Non-Current Assets

Property, Plant & Equipment25.42M

Goodwill & Intangible Assets65.72M

Long-Term Investments59.79M

Other Non-Current Assets23.66M

Total Non-Current Assets109 M

Total Assets

1.27B

Financial Health Analysis

Current Ratio

1.02x

Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.

Debt-to-Equity Ratio

9.03x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

20 M

Positive working capital, but relatively tight. The company should monitor cash flow carefully.

Asset Composition

86% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Agilon Health, Inc. Balance Sheet

AGL • NYSE

Agilon Health, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	173.7M	193.9M	114.3M	465.3M	1.1B	106.8M	123.6M
Short-Term Investments	111.4M	211.7M	380.8M	411.9M	0.0	0.0	0.0
Cash & Short-Term Investments	285.1M	405.6M	495.1M	877.2M	1.1B	106.8M	123.6M
Net Receivables	673.8M	1B	942.5M	492.4M	293.4M	144.6M	93.3M
Accounts Receivables	673.8M	0.0	0.0	492.4M	0.0	144.6M	93.3M
Other Receivables	0.0	1B	942.5M	0.0	293.4M	0.0	0.0
Prepaids	0.0	0.0	0.0	0.0	0.0	9.6M	4.3M
Other Current Assets	137.8M	35.1M	42.5M	81.7M	19M	33.2M	24.3M
Total Current Assets	1.1B	1.5B	1.5B	1.5B	1.4B	294.2M	245.5M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	25.4M	37M	41M	32M	20.9M	16M	18.8M
Goodwill	0.0	24.1M	24.1M	2.5M	0.0	41.5M	41.5M
Intangible Assets	65.7M	72.8M	63.8M	18.4M	96.9M	60.5M	71.1M
Goodwill & Intangible Assets	65.7M	96.9M	87.9M	21M	96.9M	102M	112.7M
Long-Term Investments	59.8M	61.8M	44.8M	17.4M	6.7M	8.5M	0.0
Other Non-Current Assets	23.7M	80.6M	87.1M	175.9M	94.5M	25.6M	25.7M
Total Non-Current Assets	174.6M	276.2M	260.8M	246.2M	219.1M	152.2M	157.3M
Total Assets	1.3B	1.7B	1.7B	1.7B	1.6B	446.4M	402.8M
LIABILITIES
CURRENT LIABILITIES
Total Payables	1.1B	1.1B	968.1M	478.2M	348.7M	260.1M	61.7M
Accounts Payable	1.1B	1.1B	968.1M	478.2M	348.7M	260.1M	61.7M
Short Term Debt	19.2M	2.5M	9.1M	5M	8.3M	3M	3M
Other Current Liabilities	0.0	0.0	0.0	51.9M	0.0	3.7M	134.9M
Total Current Liabilities	1.1B	1.2B	977.2M	535.1M	357M	266.8M	199.6M
NON-CURRENT LIABILITIES
Long Term Debt	15.8M	34.9M	32.3M	38.5M	43.4M	64.7M	67.1M
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	281.1M
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	10M	12.8M
Other Non-Current Liabilities	50.5M	69.5M	59.5M	74.2M	86.4M	384.1M	79.2M
Total Non-Current Liabilities	68.1M	111M	102.7M	121.8M	137.7M	464.3M	435.2M
Capital Lease Obligations	1.8M	6.6M	10.9M	9.1M	7.9M	5.5M	7.7M
Total Liabilities	1.1B	1.3B	1.1B	656.9M	494.7M	731.1M	634.8M
SHAREHOLDERS' EQUITY
Common Stock	4.1M	4.1M	4.1M	4.1M	4M	2.5M	2.5M
Additional Paid-In Capital	2.1B	2.1B	2B	2.1B	2B	264M	256.6M
Retained Earnings	-2B	-1.6B	-1.3B	-1.1B	-957.7M	-551.2M	-491.1M
Accumulated Other Comprehensive Income/Loss	916K	-88K	-2.3M	-5.6M	0.0	0.0	0.0
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	2.4M
Total Stockholders' Equity	126.7M	471M	661.8M	1B	1.1B	-284.7M	-232M
Total Equity	126.7M	471M	661M	1B	1.1B	-284.7M	-232M
Minority Interest	0.0	0.0	-818K	-611K	-300K	0.0	0.0
SUMMARY
Total Liabilities & Equity	1.3B	1.7B	1.7B	1.7B	1.6B	446.4M	402.8M
Total Investments	171.2M	273.5M	425.5M	429.3M	6.7M	8.5M	0.0
Total Debt	36.8M	44M	52.3M	52.6M	59.6M	73.2M	77.9M
Net Debt	-136.9M	-149.9M	-62M	-412.7M	-995.2M	-33.6M	-45.7M
Shares Outstanding	414,423,149	414,423,149	414,423,149	414,423,149	414,423,149	414,423,149	414,423,149

SEC Filings

AGL - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	June 03, 2026	June 02, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 06, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 06, 2026	May 06, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 27, 2026	April 24, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 22, 2026	June 02, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 30, 2026	March 30, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 18, 2026	March 17, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 25, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 25, 2026	February 25, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	February 18, 2026	March 17, 2026	2026	View Filing

Showing 1 to 10 of 86 filings

Related Guides

Blog Categories

Continue your AGL research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.